phosphotyrosine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaji, SA; Califano, JA; Chatterjee, A; Chavan, S; Gowda, H; Jain, AP; Kumar, MM; Mathur, PP; Nanjappa, V; Pandey, A; Pinto, SM; Prasad, TS; Puttamallesh, VN; Radhakrishnan, A; Raja, R; Rangarajan, A; Sahasrabuddhe, NA; Santosh, V; Sathe, G; Sidransky, D; Sukumar, G | 1 |
1 other study(ies) available for phosphotyrosine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
Topics: Animals; Apoptosis; bcl-X Protein; Carcinoma, Squamous Cell; Caspase 9; Cell Line; Cell Movement; Dyrk Kinases; Female; Forkhead Box Protein O3; Harmine; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Small Molecule Libraries; Squamous Cell Carcinoma of Head and Neck; Tandem Mass Spectrometry; Tissue Array Analysis; Transplantation, Heterologous | 2016 |